Natural Alternatives International, Inc. (NAII) Stock

Natural Alternatives International, Inc. (NAII) is a Healthcare stock trading at $2.68 (as of 2026-06-18), with a market capitalization of $15.07M and a trailing P/E of -1.1. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Natural Alternatives International, Inc. formulates, manufactures, and markets nutritional supplements and related health care products, selling its services in the United States and internationally. It operates through private-label contract manufacturing for customer-branded supplement products and through patent and trademark licensing, and it also sells beta-alanine ingredients under the CarnoSyn and SR CarnoSyn names.

Valuation — source: SEC EDGAR (first-party)
Price	$2.68
Market Cap	$15.07M
P/E Ratio	-1.1
EV / EBITDA	-2.4
Price / Book	0.25
Price / Sales	0.11
DCF Value (model)	$7.21
DCF Upside vs Price	169.0%

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$129.86M
Net Margin	-10.5%
Return on Equity	-22.8%
Current Ratio	1.64
Revenue Growth (YoY)	23.3%
EPS Growth (YoY)	94.6%
FCF Growth (YoY)	-2650.0%

Financial Health — source: SEC EDGAR
Altman Z-Score	1.57 (distress)

Valuation vs Sector & Industry
Stock P/E	-1.1
Sector P/E (Healthcare)	20.9
Industry P/E (Pharmaceutical Products)	17.0
vs Sector	-105.1%
vs Industry	-106.2%

Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holder	CALDWELL SUTTER CAPITAL, INC. ($1.31M)
Institutional Holders Tracked	10

Company
Sector	Healthcare
Industry	Pharmaceutical Products
CEO	Mark A. LeDoux
Employees	296
Country	US
IPO Date	1993-10-28

Related Companies (Business model: Branded Consumer (CPG, Staples, Beauty, Alcohol, Pet, Nicotine); 8 closest by market cap; US-domiciled)

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.